---
title: "Rainbow Childrens Medicare Ltd (RAINBOW) — Share Price, Financials & Analysis"
symbol: "RAINBOW"
company: "Rainbow Childrens Medicare Ltd"
canonical: "https://tapetide.com/stocks/RAINBOW"
isin: "INE961O01016"
nse_symbol: "RAINBOW"
bse_code: "543524"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 14645.85
generated_at: "2026-09-13T18:37:45.183Z"
---

# Rainbow Childrens Medicare Ltd (RAINBOW)

Canonical page: https://tapetide.com/stocks/RAINBOW

## Company

- **NSE Symbol:** RAINBOW
- **BSE Code:** 543524
- **ISIN:** INE961O01016
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2022-05-10
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** rainbowhospitals.in

## About

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

## Latest Price

- **Price:** ₹1444.9
- **Change:** -15.2 (-1.04%)
- **Open:** ₹1453.5
- **Day High:** ₹1461.7
- **Day Low:** ₹1430.1
- **Previous Close:** ₹1460.1
- **Volume:** 82388
- **As Of:** 2026-09-11T10:22:49+00:00

## Key Fundamentals

Observed at 2026-09-11T04:50:51.655639Z.

- **Market Cap:** ₹14645.85 Cr
- **Classification:** Microcap
- **P/E (reported):** 51.1
- **P/E (TTM):** 51.42
- **EPS (TTM):** ₹28.1
- **EPS (reported):** ₹21.23
- **Book Value:** ₹164.36
- **Price to Book:** 8.89
- **Dividend Yield:** 0.24%
- **ROE:** 16.92%
- **ROCE:** 16.84%
- **Debt to Equity:** 0.54
- **Revenue (yearly):** ₹1746.9 Cr
- **Net Income:** ₹281.5 Cr
- **EBITDA:** ₹588 Cr
- **52-Week High:** ₹1610
- **52-Week Low:** ₹1084
- **RSI (14):** 50.07

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 28.36 | 9% |
| growth | 53.79 | 9% |
| momentum | 49.51 | 12% |
| ownership | 50.45 | 24% |
| quality | 57.94 | 22% |
| valuation | 34.67 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company's median sales growth is 22.8% of last 10 years

### Weaknesses

- Stock is trading at 8.90 times its book value

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 6.07% | 30.57% | 87.57% |
| ebitda margin growth | -0.54% | -2.49% | -3.64% | 3.19% |
| net income growth | -20.08% | 15.27% | 6% | 44% |
| revenue growth | 3.81% | 11.49% | 13% | 21% |
| roce | -1.99% | -6.86% | -3.83% | 18.73% |
| roe | -20.05% | 2.17% | 16.91% | -26.02% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 333 | 336 | 341 | 330 | 417 | 398 | 370 | 353 | 445 | 445 | 460 | 470 |
| Expenses | 215 | 218 | 236 | 236 | 270 | 264 | 255 | 249 | 296 | 298 | 315 | 335 |
| Operating Profit | 118 | 118 | 106 | 94 | 147 | 134 | 115 | 104 | 149 | 147 | 145 | 135 |
| OPM % | 35 | 35 | 31 | 28 | 35 | 34 | 31 | 29 | 33 | 33 | 31 | 29 |
| Other Income | 8 | 9 | 13 | 12 | 11 | 13 | 15 | 20 | 8 | 11 | 4 | 13 |
| Interest | 13 | 14 | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 20 | 20 | 21 |
| Depreciation | 27 | 28 | 32 | 34 | 35 | 35 | 34 | 34 | 36 | 40 | 41 | 42 |
| Profit before tax | 85 | 85 | 69 | 53 | 105 | 94 | 77 | 71 | 102 | 98 | 87 | 84 |
| Tax % | 26 | 26 | 26 | 26 | 25 | 27 | 27 | 25 | 26 | 24 | 10 | 26 |
| Net Profit | 63 | 63 | 51 | 40 | 79 | 69 | 57 | 54 | 76 | 74 | 78 | 63 |
| EPS in Rs | 6.2 | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 | 7.14 | 7.59 | 5.96 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 402 | 543 | 719 | 650 | 974 | 1174 | 1297 | 1516 | 1703 | 1820 |
| Expenses | 332 | 391 | 519 | 485 | 666 | 774 | 865 | 1022 | 1155 | 1245 |
| Operating Profit | 69 | 151 | 201 | 165 | 308 | 400 | 432 | 494 | 548 | 575 |
| OPM % | 17 | 28 | 28 | 25 | 32 | 34 | 33 | 33 | 32 | 32 |
| Other Income | 10 | 8 | 10 | 10 | 19 | 31 | 37 | 51 | 42 | 35 |
| Interest | 4 | 42 | 48 | 46 | 56 | 58 | 63 | 77 | 82 | 81 |
| Depreciation | 28 | 60 | 69 | 73 | 83 | 90 | 112 | 138 | 151 | 159 |
| Profit before tax | 47 | 58 | 93 | 56 | 187 | 282 | 295 | 330 | 358 | 371 |
| Tax % | 22 | 22 | 41 | 29 | 26 | 25 | 26 | 26 | 21 | — |
| Net Profit | 36 | 45 | 55 | 40 | 139 | 212 | 218 | 244 | 282 | 290 |
| EPS in Rs | 8.25 | 10.14 | 12.68 | 9.1 | 14.7 | 20.77 | 21.38 | 23.97 | 27.4 | 28.1 |
| Dividend Payout % | 12 | 10 | 16 | 0 | 14 | 14 | 14 | 13 | 13 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
| Reserves | 308 | 307 | 317 | 350 | 391 | 498 | 958 | 1157 | 1367 | 1547 |
| Borrowings | 26 | 24 | 476 | 501 | 529 | 592 | 570 | 765 | 764 | 891 |
| Other Liabilities | 55 | 73 | 89 | 123 | 116 | 112 | 140 | 146 | 145 | 236 |
| Total Liabilities | 399 | 448 | 926 | 1019 | 1081 | 1296 | 1771 | 2170 | 2377 | 2775 |
| Fixed Assets | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1253 | 1398 | 1756 |
| CWIP | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 28 | 79 |
| Investments | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 | 404 |
| Other Assets | 212 | 140 | 199 | 265 | 262 | 409 | 759 | 590 | 380 | 535 |
| Total Assets | 399 | 448 | 926 | 1019 | 1081 | 1296 | 1771 | 2170 | 2377 | 2775 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 36 | 48 | 127 | 170 | 143 | 224 | 329 | 321 | 396 | 420 |
| Cash from Investing Activity | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -226 | -268 | -259 |
| Cash from Financing Activity | -1 | -7 | -9 | -52 | -61 | -44 | 143 | -102 | -118 | -147 |
| Net Cash Flow | 1 | -2 | 2 | 2 | -1 | 4 | 7 | -7 | 10 | 14 |
| Free Cash Flow | -21 | -103 | 42 | 96 | 67 | 162 | 188 | -32 | 250 | 204 |
| CFO/OP | 79 | 88 | 94 | 95 | 102 | 93 | 103 | 95 | 97 | 95 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 16 | 14 | 24 | 22 | 25 | 15 | 16 | 20 | 19 | 22 |
| Inventory Days | 48 | 36 | 32 | 55 | 36 | 28 | 43 | 53 | 52 | 67 |
| Days Payable | 142 | 151 | 197 | 202 | 190 | 121 | 182 | 180 | 170 | 162 |
| Cash Conversion Cycle | -79 | -100 | -141 | -124 | -130 | -78 | -123 | -107 | -100 | -73 |
| Working Capital Days | -28 | -31 | -26 | -18 | -17 | -16 | 73 | 43 | 19 | 8 |
| ROCE % | 14 | 14 | 16 | 16 | 11 | 23 | 24 | 19 | 19 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 49.83% | 49.83% | 49.83% | 49.88% | 49.85% | 49.85% | 49.85% | 49.85% | 49.85% | 49.84% | 49.84% | 49.84% |
| FIIs | 21.63% | 22.32% | 24.04% | 24.78% | 25.11% | 25.12% | 23.69% | 23.59% | 21.85% | 19.23% | 17.24% | 16.03% |
| DIIs | 15.4% | 15.62% | 14.76% | 13.8% | 13.83% | 13.87% | 15.31% | 15.44% | 17.46% | 19.49% | 21.13% | 22.56% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.92% | 11.03% | 10.4% | 10.74% | 10.4% | 10.38% | 10.34% | 10.32% | 10.06% | 10.49% | 10.7% | 10.41% |
| Others | 1.22% | 1.21% | 0.97% | 0.8% | 0.8% | 0.77% | 0.79% | 0.79% | 0.78% | 0.95% | 1.1% | 1.16% |
| No. of Shareholders | 79187 | 80471 | 77152 | 78557 | 77524 | 78764 | 79092 | 80320 | 81134 | 88809 | 88561 | 89305 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 7 / 7

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1445.8 | Sell |
| EMA (10) | 1450.38 | Sell |
| SMA (20) | 1448.98 | Sell |
| EMA (20) | 1455.75 | Sell |
| SMA (50) | 1477.15 | Sell |
| EMA (50) | 1453.19 | Sell |
| SMA (100) | 1413.41 | Buy |
| EMA (100) | 1416.78 | Buy |
| SMA (200) | 1327.21 | Buy |
| EMA (200) | 1380.93 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.34 | Neutral |
| MACD (12,26,9) | -7.45 | Buy |
| Stochastic (14,3,3) | 54.52 | Neutral |
| ADX (14) | 17.76 | Neutral |
| Williams %R (14) | -54.6 | Neutral |
| ATR (14) | 37.14 | Neutral |
| ROC (12) | -0.12 | Sell |
| Stoch RSI (14) | 61.71 | Neutral |
| UO (7,14,28) | 44.35 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 9 | 90% |
| Hold | 1 | 10% |
| Sell | 0 | 0% |

Based on 10 analyst ratings, observed at 2026-09-11T04:50:51.653001+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 May - GST appeal against May 29, 2024 demand disallowed; company plans further appeal. | [Update On Ongoing Tax Litigation 8 May - GST appeal against May 29, 2024 demand disallowed; company plans further appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/427e55f3-283d-40d2-b536-0816a67879f5.pdf) |
| 8 Apr - Rainbow Hospitals clarified unusual trading volume was market-driven, with no undisclosed material event. | [Clarification On Movement In Volume Of Securities. 8 Apr - Rainbow Hospitals clarified unusual trading volume was market-driven, with no undisclosed material event.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e01cb1b-3be2-4382-a503-eb762ae18449.pdf) |
| 6 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7223533c-1838-412b-97e2-7179e450206e.pdf) |
| 4 May - Rainbow opened a 60-bed HRBR hospital and Mahadevapura IVF centre on May 4, 2026; ₹52 crore capex. | [Commencement Of New Spoke Hospital In HRBR Layout, Hennur And Mahadevpura IVF Centre. 4 May - Rainbow opened a 60-bed HRBR hospital and Mahadevapura IVF centre on May 4, 2026; ₹52 crore capex.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e9c1eed-4018-4669-9241-a4d9ca316ced.pdf) |
| 4 May - Rainbow opened a 60-bed HRBR hospital and Mahadevapura IVF centre on May 4, 2026; ₹52 crore capex. | [Commencement Of New Spoke Hospital In HRBR Layout, Hennur And Mahadevpura IVF Centre. 4 May - Rainbow opened a 60-bed HRBR hospital and Mahadevapura IVF centre on May 4, 2026; ₹52 crore capex.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3e9c1eed-4018-4669-9241-a4d9ca316ced.pdf) |
| 29 Jan - Audio recording of Q3 & 9M FY26 earnings call posted (Jan 29, 2026). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 29 Jan - Audio recording of Q3 & 9M FY26 earnings call posted (Jan 29, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80a29738-e95b-4c98-b139-696c57867a50.pdf) |
| 28 Jan - Earnings Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Investor Presentation 28 Jan - Earnings Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/032ce313-d359-4e1a-9e74-6f03111689b4.pdf) |
| 25 Mar - Trading window closed from April 1, 2026 until 48 hours after audited financial results for year ended March 31, 2026. | [Closure of Trading Window 25 Mar - Trading window closed from April 1, 2026 until 48 hours after audited financial results for year ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5648a4d1-03cf-48fe-8763-ccf6467ddfcf.pdf) |
| 24 Apr - White Oak reported 2.80% holding in Rainbow Childrens Medicare after 20,38,948 shares on April 21, 2026. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 24 Apr - White Oak reported 2.80% holding in Rainbow Childrens Medicare after 20,38,948 shares on April 21, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4D5E91E6_0BFB_45B9_A2F2_A07A98744F55_104531.pdf) |
| 16h - White Oak reported 2.80% holding in Rainbow Childrens Medicare after 20,38,948 shares on April 21, 2026. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 16h - White Oak reported 2.80% holding in Rainbow Childrens Medicare after 20,38,948 shares on April 21, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4D5E91E6_0BFB_45B9_A2F2_A07A98744F55_104531.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Cessation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e214c3-8133-4cce-b149-6755e21507ac.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d4336b5-86ae-4240-9f4d-9be1002f0980.pdf) |
| 2026-08-14 | [Update On Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd2cda3c-d205-4ba0-87a8-6c1ed77ec774.pdf) |
| 2026-07-31 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23639fd2-b644-4ac8-9856-96d8d9cfc6ac.pdf) |
| 2026-07-30 | [Board Meeting Outcome for Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7713691-5802-463f-81c8-afc36ebc3033.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1029d865-4285-417c-8df5-034be1cd128f.pdf) |
| 2026-07-30 | [Intimation Regarding Grant Of Options Under Employee Stock Option Scheme 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cddc093c-d32c-4061-a890-306f25ff77ae.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0029643c-876e-4abd-ad02-6d016fd7ed1c.pdf) |
| 2026-07-29 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffa88077-5a4a-4923-a413-6953934c8a74.pdf) |
| 2026-07-29 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b16d399e-cdd7-4b93-b4cb-a11539121ec1.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8970d382-3968-4128-9b4c-cddf4546db10.pdf) |
| 2026-06-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00f2af46-b715-47b0-9821-c0eb807fea45.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54d134c3-7f93-472b-989b-7a62cbe023d9.pdf) |
| 2025-11-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94b5944b-a643-4e16-a1f0-3f204d44c318.pdf) |
| 2025-08-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0598f669-5989-41b4-95c5-53dc948bf14f.pdf) |
| 2025-05-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70f0bace-eab0-4682-8a92-2d3f2cfe89b7.pdf) |
| 2025-02-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37a8bbfd-5751-4f66-b98a-1073c68ada59.pdf) |
| 2024-11-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be44ff22-0967-45e4-b0d4-dc34cd56f9ac.pdf) |
| 2024-08-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d662cb3-c445-44eb-a922-7fd8ad879a1d.pdf) |
| 2024-05-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7be92a5-6115-463c-843d-cf0c37e7bb01.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72f1dc2e-93bd-4229-82ec-5338b30404b0.pdf) |
| 2026-05-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5a9ac79-e8a4-4978-8c7b-9f7ae5498f0e.pdf) |
| 2026-01-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80a29738-e95b-4c98-b139-696c57867a50.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64ef2fd9-10c7-43e1-94b5-641f9c8cd4b4.pdf) |
| 2025-07-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77934edf-36d1-4760-bc8d-5ebcc8f4c150.pdf) |
| 2025-05-26 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f9784d6-2aef-473a-a55a-c7ffadbf1657.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=781e138c-2785-4743-8131-f84e8a27b234.pdf) |
| 2024-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9abe30f3-0143-4a92-93e5-2a76724b067c.pdf) |
| 2024-05-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76109de8-cbb7-456e-afd8-1381dc8c7672.pdf) |
| 2024-01-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba1aa86-6f1c-4b0e-9e82-e3a7c65e425a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-30 | [Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d0402fe-9ffc-41d5-94c7-7bd3a03b8b97.pdf) |
| 2026-05-27 | [March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a62ae854-24f8-4100-ba8f-b9a95af71f48.pdf) |
| 2026-05-27 | [March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5d6c739-6297-44c1-8c2f-e4b6e53354df.pdf) |
| 2026-01-28 | [Unaudited Financial Results For Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f3d0538-b000-48ba-99b2-c1341bb436b2.pdf) |
| 2025-11-13 | [Unaudited Financial Results Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fc04d5d-f099-4deb-9bb2-66c87cdf0c45.pdf) |
| 2025-07-26 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6036cac7-ddd0-4af0-aac1-ad638f96d915.pdf) |
| 2025-05-24 | [Audited Financial Results For The Quarter And Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1105eea-b434-4133-91ce-6c96dabb614b.pdf) |
| 2025-02-09 | [Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26598283-9dac-456b-bda1-f8088d5af42c.pdf) |
| 2024-10-27 | [Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=534a6906-a11e-4492-a2c4-b77bd0461426.pdf) |
| 2024-08-13 | [Un-Audited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e615ae69-8745-49f7-be7c-958507173a95.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb803ec1-af0b-4134-a12d-4892a60d2233.pdf) |
| 2026-05-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e2d6456-83ef-4799-b053-94ffe50d1b7a.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=032ce313-d359-4e1a-9e74-6f03111689b4.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=101ae4ea-97d3-4af1-b0a0-27de988dd09a.pdf) |
| 2025-07-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b162b8c-e023-45c6-bef1-64c795280197.pdf) |
| 2025-05-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01e10600-be84-4086-835a-bc0aee61bdc6.pdf) |
| 2025-02-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=644542b5-b3a3-4dd1-af12-0917a4759872.pdf) |
| 2024-10-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54a60e73-780b-436a-847a-f348c52d3310.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ac4f39a-5363-4553-8d04-223e444b3d96.pdf) |
| 2024-05-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a6cd21-784f-49d8-8b75-f43897f04d98.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/94b5944b-a643-4e16-a1f0-3f204d44c318.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be44ff22-0967-45e4-b0d4-dc34cd56f9ac.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/26b6aa71-792b-47c9-b335-16573ebe2f01.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c224077-b1e0-4059-8198-abf6bc6b43c8.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c224077-b1e0-4059-8198-abf6bc6b43c8.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e0850042-0043-4607-85b4-7e1656477b78.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1e2d6456-83ef-4799-b053-94ffe50d1b7a.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1e2d6456-83ef-4799-b053-94ffe50d1b7a.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70f0bace-eab0-4682-8a92-2d3f2cfe89b7.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7be92a5-6115-463c-843d-cf0c37e7bb01.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f768a857-d043-405e-9fa0-da47ed96aabf.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/327a28a5-24ea-4672-81e7-85631103aabc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/524c672a-a8c8-4bd1-add0-1d63859bd503.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eaebdde2-2dab-4729-9ce2-5bcfa67c39bd.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543524/74634543524.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:45.183Z.